Edgepharma Limited in London, W1U 3PP

Description

Data updated on: 01-11-2023

The firm called Edgepharma was started on 2017/01/24 as a Private Limited Company. This business's registered office could be gotten hold of in London on Milner House, 14 Manchester Square. Should you need to reach the firm by post, the zip code is W1U 3PP. The reg. no. for Edgepharma Limited is 10581135. This business's SIC code is 96090 meaning Other service activities not elsewhere classified. Thu, 30th Jun 2022 is the last time the accounts were reported.

With regards to this business, the full extent of director's tasks have so far been done by Geoffrey M. who was appointed on 2017/01/24.

Geoffrey M. is the individual who has control over this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30
Currency	EUR	EUR	EUR	EUR	EUR	EUR

Balance Sheet
Cash Bank On Hand	1 049 944	1 749 401	12 048	20 252	126 047	44 087
Current Assets	1 147 173	2 596 362	109 009	117 213	223 008	209 721
Debtors	97 230	846 961	96 961	96 961	96 961	165 634
Net Assets Liabilities	32 743	13 713	-227 819	-219 616	-220 279	-237 394
Other Debtors	268			-1 559		68 673

Other Financial Data
Accrued Liabilities Deferred Income	9 180	1 226	1 226	1 226	1 226	6 226
Administrative Expenses	64 840	44 029	261 737	2 603	663	32 228
Cash Cash Equivalents Cash Flow Value	1 049 942	1 749 401	12 048	20 252	126 047	44 087
Comprehensive Income Expense	32 741	-19 030	-241 532	8 203	-663	-17 115
Corporation Tax Recoverable				1 559
Creditors	9 180	2 582 649	336 828	336 829	443 287	447 115
Current Tax For Period	7 956
Gain Loss In Cash Flows From Change In Accrued Items	9 180	-7 954				5 000
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables	1 105 250	1 476 173	-2 245 821	1	106 458	-1 172
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables	-97 229	-749 732	750 000			-68 673
Gain Loss On Non-financing Activities Due To Foreign Exchange Differences Recognised In Profit Or Loss	-17 926	-131	17 272	621	-621	-5 601
Gross Profit Loss	105 539	25 000	20 230	10 806		15 113
Income Taxes Paid Refund Classified As Operating Activities	7 956
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation	1 049 942	699 457	-1 737 353	8 204	105 795	-81 960
Interest Expense On Bank Overdrafts Bank Loans Similar Borrowings	2	1	25
Interest Paid Classified As Operating Activities	2	1	25
Interest Payable Similar Charges Finance Costs	2	1	25
Net Cash Flows From Used In Operating Activities	1 049 942	699 457	-1 737 353	8 204	105 795	-81 960
Net Cash Generated From Operations	1 057 900	699 458	-1 737 328	8 204	105 795	-81 960
Net Current Assets Liabilities	1 137 994	13 713	-227 819	-219 616	-220 279	-237 394
Number Shares Issued Fully Paid	1	1	1	1	1	1
Operating Profit Loss	40 699	-19 029	-241 507	8 203	-663	-17 115
Other Taxation Social Security Payable		1 173	1 173	1 173	1 173
Par Value Share	1	2	2	2	2	2
Profit Loss	32 741	-19 030	-241 532	8 203	-663	-17 115
Profit Loss On Ordinary Activities Before Tax	40 697	-19 030	-241 532	8 203	-663	-17 115
Revenue From Rendering Services		25 000	20 230
Tax Tax Credit On Profit Or Loss On Ordinary Activities	7 956
Total Assets Less Current Liabilities	1 137 994	13 713	-227 819	-219 616	-220 279	-237 394
Trade Creditors Trade Payables	1 105 250	2 580 250	334 429	334 430	440 888	440 889
Trade Debtors Trade Receivables	96 961	846 961	96 961	96 961	96 961	96 961
Turnover Revenue	105 539	25 000	20 230	10 806		15 113
Number Shares Allotted	2

Company staff

Geoffrey M.

Role: Director

Appointed: 24 January 2017

Latest update: 23 February 2024

People with significant control

Geoffrey M.

Notified on 24 January 2017

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Accounts Documents

Account next due date	31 March 2024
Account last made up date	30 June 2022
Confirmation statement next due date	17 October 2024
Confirmation statement last made up date	03 October 2023

Annual Accounts
Start Date For Period Covered By Report	2018-01-02
End Date For Period Covered By Report	2018-06-30
Annual Accounts
Start Date For Period Covered By Report	2018-07-01
End Date For Period Covered By Report	30 June 2019
Annual Accounts
Start Date For Period Covered By Report	2019-07-01
End Date For Period Covered By Report	30 June 2020
Annual Accounts
Start Date For Period Covered By Report	2020-07-01
End Date For Period Covered By Report	30 June 2021
Annual Accounts
Start Date For Period Covered By Report	2021-07-01
End Date For Period Covered By Report	30 June 2022
Annual Accounts
Start Date For Period Covered By Report	2022-07-01
End Date For Period Covered By Report	30 June 2023

Edgepharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Geoffrey M.

Limestar Investments Limited

People with significant control

Geoffrey M.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies